OurBrainBank in Forbes: White House War on GBM and more
Ed Pilkington writes about his experiences and how the White House is working to improve treatment for GBM and all cancers.
Read more
OurBrainBank Wins Forbes EQ BrandVoice 2024: First Article Features Jessica Morris’s book
OBB founder Jessica Morris’s book is excerpted by Forbes.
UK ranks 22nd out of 29 comparable countries for survival of Brain Cancer
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
Experimental GBM treatment — DC Vax — is hoped to be moving forward in the UK
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
White House Cancer Moonshot
OurBrainBank is proud that the White House invited us to be part of the ambitious Cancer Moonshot effort. Read the latest from Washington DC.
OurBrainBank at SNO — Society for Neuro-Oncology — Annual Conference
Executive Director Kelli Duprey presented our poster about treatment disparities at SNO 2023
Clinical trial for people newly diagnosed with glioblastoma
Clinical trial for people newly diagnosed with glioblastoma
GBM Patient & Carer support and informational videos
Connect with others also affected by glioblastoma—give and get support, information, and resources.
Guide to sponsored patient support programs from pharma and device companies
Each year, Oncology Practice Management updates this comprehensive guide to sponsored patient support programs.
Running the Brighton Marathon to benefit OurBrainBank UK
Founder Jessica Morris’s family is running the Brighton marathon to raise funds for OurBrainBank!
SUBSCRIBE TO OUR NEWSLETTER
GET INVOLVED
